NBIX

NASDAQ · Biotechnology

Neurocrine Biosciences Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$163.41

+3.59 (+2.25%)

As of Aug 8, 9:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 86%

Hold 5 14%

Sell 0 0%

Price Target

Analyst Price Target -22.3% upside

Low Target $104.30

Average Target $126.93

High Target $177.55

Current Price $163.41

Current
$163.41

Target
$126.93

$104.30 $126.93 avg $177.55

Scenario Analysis

Bear Case

$104.30

-36.2%

Low target

Base Case

$126.93

-22.3%

Avg target

Bull Case

$177.55

+8.7%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$186.12

-12.2% from high

52-Week Low

$122.14

+33.8% from low

50-Day SMA

$139.44

+17.2% vs SMA

200-Day SMA

$135.94

+20.2% vs SMA

RSI (14)

38.6

Neutral

Target vs 52W High

$126.93

-31.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.0%